By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension
Overview
Focuses on how pulmonary hypertension (PH) may involve multiple clinical conditions and pose complications for the majority of cardiovascular and respiratory diseases.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: January 1, 2016
Contact: practice@apta.org
Content Type: CPG
Galiè N, Humbert M, Vachiery JL, et al; European Society of Cardiology, European Respiratory Society
You Might Also Like...
CPG
VA/DoD Clinical Practice Guideline for the Management of Dyslipidemia for Cardiovascular Risk Reduction (Revised, 4.0)Jun 1, 2020
This guideline describes the critical decision points in the management of Dyslipidemia (LIPIDS) and provides clear and comprehensive evidence based
CPG
Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and ChildrenMay 1, 2020
These guidelines address the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children, including new guidance on the
CPG
Hypertension in Adults: Diagnosis and Management [NICE NG136]Aug 28, 2019
Covers identifying and treating primary hypertension in people aged 18 and over, including people with type 2 diabetes.